| 1 | commonly | 11,300 |
| 2 | popularly | 120 |
| 3 | changes.we | 3 |
| 4 | regulary | 3 |
| 5 | less-frequently | 2 |
| 6 | non-conventionally | 2 |
| 7 | questionnaire-self | 2 |
| 8 | significantbridging | 2 |
| 9 | were/are | 2 |
| 10 | -widely | 1 |
| 11 | -γ-cyclodextrin | 1 |
| 12 | 1971-89 | 1 |
| 13 | 21,011 | 1 |
| 14 | 9595 | 1 |
| 15 | anesthetic/sedation | 1 |
| 16 | beta-adrenolytics | 1 |
| 17 | beta-minetic | 1 |
| 18 | complimentarily | 1 |
| 19 | decision.patients | 1 |
| 20 | discmonitor | 1 |
| 21 | diviner-mediums | 1 |
| 22 | ef5-hand | 1 |
| 23 | endo-clips | 1 |
| 24 | fibrinopeptide-a | 1 |
| 25 | folkloricly | 1 |
| 26 | forms/month | 1 |
| 27 | injectant | 1 |
| 28 | lare | 1 |
| 29 | main-acupoint | 1 |
| 30 | meta-analyses.we | 1 |
| 31 | model-bl | 1 |
| 32 | morpholines | 1 |
| 33 | movalis | 1 |
| 34 | noncorticosteroids | 1 |
| 35 | pharmacopunctures | 1 |
| 36 | plants/agents | 1 |
| 37 | psychotherapy/psychopharmacotherapy | 1 |
| 38 | received/diet | 1 |
| 39 | respondants | 1 |
| 40 | skiboot | 1 |
| 41 | slow-speaking | 1 |
| 42 | statistical-methods | 1 |
| 43 | studies.when | 1 |
| 44 | sutides | 1 |
| 45 | technology/automation | 1 |
| 46 | telemanipulators | 1 |
| 47 | tgf-β1/il-10 | 1 |
| 48 | thermoeffectors | 1 |
| 49 | thromboplastins | 1 |
| 50 | vivagel® | 1 |
| 1 | -widely | 1 |
| 2 | -γ-cyclodextrin | 1 |
| 3 | 1971-89 | 1 |
| 4 | 21,011 | 1 |
| 5 | 9595 | 1 |
| 6 | anesthetic/sedation | 1 |
| 7 | beta-adrenolytics | 1 |
| 8 | beta-minetic | 1 |
| 9 | changes.we | 3 |
| 10 | commonly | 11,300 |
| 11 | complimentarily | 1 |
| 12 | decision.patients | 1 |
| 13 | discmonitor | 1 |
| 14 | diviner-mediums | 1 |
| 15 | ef5-hand | 1 |
| 16 | endo-clips | 1 |
| 17 | fibrinopeptide-a | 1 |
| 18 | folkloricly | 1 |
| 19 | forms/month | 1 |
| 20 | injectant | 1 |
| 21 | lare | 1 |
| 22 | less-frequently | 2 |
| 23 | main-acupoint | 1 |
| 24 | meta-analyses.we | 1 |
| 25 | model-bl | 1 |
| 26 | morpholines | 1 |
| 27 | movalis | 1 |
| 28 | non-conventionally | 2 |
| 29 | noncorticosteroids | 1 |
| 30 | pharmacopunctures | 1 |
| 31 | plants/agents | 1 |
| 32 | popularly | 120 |
| 33 | psychotherapy/psychopharmacotherapy | 1 |
| 34 | questionnaire-self | 2 |
| 35 | received/diet | 1 |
| 36 | regulary | 3 |
| 37 | respondants | 1 |
| 38 | significantbridging | 2 |
| 39 | skiboot | 1 |
| 40 | slow-speaking | 1 |
| 41 | statistical-methods | 1 |
| 42 | studies.when | 1 |
| 43 | sutides | 1 |
| 44 | technology/automation | 1 |
| 45 | telemanipulators | 1 |
| 46 | tgf-β1/il-10 | 1 |
| 47 | thermoeffectors | 1 |
| 48 | thromboplastins | 1 |
| 49 | vivagel® | 1 |
| 50 | were/are | 2 |
| 1 | tgf-β1/il-10 | 1 |
| 2 | 21,011 | 1 |
| 3 | 9595 | 1 |
| 4 | 1971-89 | 1 |
| 5 | fibrinopeptide-a | 1 |
| 6 | beta-minetic | 1 |
| 7 | ef5-hand | 1 |
| 8 | were/are | 2 |
| 9 | lare | 1 |
| 10 | changes.we | 3 |
| 11 | meta-analyses.we | 1 |
| 12 | questionnaire-self | 2 |
| 13 | significantbridging | 2 |
| 14 | slow-speaking | 1 |
| 15 | forms/month | 1 |
| 16 | model-bl | 1 |
| 17 | studies.when | 1 |
| 18 | -γ-cyclodextrin | 1 |
| 19 | anesthetic/sedation | 1 |
| 20 | technology/automation | 1 |
| 21 | discmonitor | 1 |
| 22 | beta-adrenolytics | 1 |
| 23 | noncorticosteroids | 1 |
| 24 | statistical-methods | 1 |
| 25 | sutides | 1 |
| 26 | morpholines | 1 |
| 27 | pharmacopunctures | 1 |
| 28 | movalis | 1 |
| 29 | diviner-mediums | 1 |
| 30 | thromboplastins | 1 |
| 31 | endo-clips | 1 |
| 32 | telemanipulators | 1 |
| 33 | thermoeffectors | 1 |
| 34 | respondants | 1 |
| 35 | plants/agents | 1 |
| 36 | decision.patients | 1 |
| 37 | received/diet | 1 |
| 38 | injectant | 1 |
| 39 | main-acupoint | 1 |
| 40 | skiboot | 1 |
| 41 | folkloricly | 1 |
| 42 | -widely | 1 |
| 43 | complimentarily | 1 |
| 44 | non-conventionally | 2 |
| 45 | commonly | 11,300 |
| 46 | popularly | 120 |
| 47 | less-frequently | 2 |
| 48 | psychotherapy/psychopharmacotherapy | 1 |
| 49 | regulary | 3 |
| 50 | vivagel® | 1 |